Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gynecologic 2Genitourinary 1

Conditions

Peritoneal Neoplasms 1Ovarian Cysts 1Hemorrhage 1Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × OTHER × FloSeal Matrix × Clear all
NCT07232927 2025-11-18

HEMOSTA-PN

Ankara University

Phase NA Completed
150 enrolled
Genitourinary

Carcinoma, Renal Cell, Hemorrhage

NCT01957852 2015-02-25

FloSeal in CRS and HIPEC

Maisonneuve-Rosemont Hospital

Completed
86 enrolled
Gynecologic

Peritoneal Neoplasms

NCT01857466 2014-06-25

Ovarian Reserve After Ovarian Hemostasis by Floseal Matrix

CHA University

Phase 3 Completed
100 enrolled
Gynecologic

Ovarian Cysts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡